VA pauses embattled Cerner EHR rollout for 6 months in major revamp

Dive Brief: The Department of Veterans Affairs isn’t scheduling any more deployments of its new Cerner EHR for six months, an agency official told a House subcommittee on Wednesday. The pause follows recent watchdog reports highlighting snowballing spending and shoddy staff training at the record’s first go-live at a VA medical center in Spokane, Washington.… Read More »

New 2021 Hybrid Cloud Management Study shows the path to cost-efficient cloud operation

Moeglingen, Germany / Boston, MA, July 21, 2021. On behalf of USU, a leading provider of IT solutions and services, the research company Research in Action has surveyed 750 decision makers from medium-sized and large companies on the challenges, solutions and savings potential of cloud services. The detailed results of the study are available free… Read More »

FDA Approves Bylvay (odevixibat) for the Treatment of Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC)

FDA Approves Bylvay (odevixibat) for the Treatment of Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC) BOSTON, July 20, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced U.S. Food & Drug Administration (FDA) approval of Bylvay (odevixibat), the first drug approved for the treatment of pruritus in… Read More »

Prescription drug ‘sticker prices’ may rise in 2021 after years of decline

The number of list price increases of prescription drugs is expected to rise in 2021, reversing a trend of the past five years. A study from 46brooklyn Research, an organization tracking drug prices, found the number of list price increases of brand-name drugs in 2021 has already exceeded the number in 2020, and it is… Read More »